Eisai
Suzanne Kelly, COC, CPPM, currently serves as the Senior Manager of Access & Reimbursement at Eisai US since June 2023. Kelly has held various roles in the pharmaceutical industry, including Field Reimbursement Manager at Ocular Therapeutix, Inc. and Field Access Manager at Novartis, where significant contributions included launching the medication Leqvio and collaborating with stakeholders to enhance patient access journeys. With prior experience as a Field Access Specialist II at Regeneron Pharmaceuticals, Kelly supported numerous biologic launches and educated healthcare providers on reimbursement processes. An accomplished Specialty Account Manager at Auxilium Pharmaceuticals, Kelly is recognized for launching Xiaflex, the first FDA-approved non-surgical treatment for Dupuytren’s Contracture. Prior to these positions, Kelly was the President of Premier Healthcare Recruiters and has extensive experience with Kos Pharmaceuticals and Roche Laboratories. Kelly holds a BS in Nutrition from Syracuse University, graduating Cum Laude.
This person is not in any teams
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.